There are many reasons to be bullish on Taiwan Semiconductor Manufacturing Company ( TSM ). The company is an unrivaled technology provider of foundational components that are required for AI development and deployment. As a result, the company plays a majorWilliam has been an avid student of the stock market for over a decade. Being an avid student of political economics his entire professional life gives him a unique insight into the macroeconomy and how it impacts assets. Having learned the value of a co ...

These ten large-cap stocks were top performers last week. Are they a part of your portfolio? Loading... Loading... ...

I analyze oil and gas companies like Ovintiv and related companies in my service, Oil & Gas Value Research, where I look for undervalued names in the oil and gas space. I break down everything you need to know about these companies -- the balance sheet, competitive position and development prospects. This article is an example of what I do. But for Oil & Gas Value Research members, they get it first and they get analysis on some companies that is not published on the free site. Interested? Sign up here for ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Marex Group plc due to allegations of securities law violations, with a deadline for investors to seek lead plaintiff status in a class action lawsuit by December 8, 2025 [3][6]. Group 1: Allegations Against Marex - The complaint alleges that Marex and its executives made false and misleading statements and failed to disclose critical information, including the sale of over-the-counter financial instruments to itself and inconsistencies in financial statements [6]. - A report from NINGI Research accused Marex of a multi-year accounting scheme involving off-balance-sheet entities and fictitious transactions, including a fabricated receivable of $17 million and nearly $1 billion in concealed derivatives exposure [7]. - Following the release of the report, Marex's stock experienced a significant decline of 6.2%, closing at $35.31 on heavy trading volume [9]. Group 2: Legal Actions and Investor Options - Investors who purchased Marex securities between May 16, 2024, and August 5, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal rights and options [2]. - The firm has a history of recovering hundreds of millions of dollars for investors since its founding in 1995, indicating its capability in handling such cases [5]. - Any member of the putative class can move the court to serve as lead plaintiff or choose to remain an absent class member, with no impact on their ability to share in any recovery [10].

MOH INVESTOR REMINDER: Faruqi & Faruqi, LLP Announces that Molina Healthcare Investors Have Opportunity to Lead Class Action LawsuitNovember 23, 2025 8:04 AM EST | Source: Faruqi & Faruqi LLPFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Molina to Contact Him Directly to Discuss Their OptionsIf you purchased or acquired securities in Molina between February 5, 2025 and July 23, 2025 and would like to discuss your legal rights, ...

Investopedia / Alison Czinkota What Is the Value of Your Used Car? Approximately 40 million used vehicles are sold each year, according to Edmunds.com, an online automotive review site. The companies tracking those sales provide an invaluable resource—detailed information on what sells and for how much. These are the figures anyone looking to buy or sell a used car needs to know to be sure they are getting a good—or at least fair—deal. Key Takeaways: Understanding How to Value Your Used Car Kelley Blue Book ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against MoonLake Immunotherapeutics due to allegations of false and misleading statements regarding its product SLK, which failed to demonstrate competitive efficacy compared to BIMZELX, leading to significant stock price decline [2][5][6][8]. Group 1: Legal Investigation - Faruqi & Faruqi, LLP is encouraging investors who suffered losses in MoonLake to contact them for discussing legal options [1]. - There is a deadline of December 15, 2025, for investors to seek the role of lead plaintiff in a federal securities class action against MoonLake [2]. - The firm has a history of recovering hundreds of millions of dollars for investors since its founding in 1995 [4]. Group 2: Allegations Against MoonLake - The complaint alleges that MoonLake and its executives violated federal securities laws by making false statements and failing to disclose material facts about the differences between Nanobodies and monoclonal antibodies [5]. - Specific allegations include misleading claims about SLK's clinical benefits and its supposed superiority over BIMZELX, which were not supported by evidence [5]. - Following the announcement of disappointing Phase 3 trial results, MoonLake's stock price fell by $55.75 per share, or 89.9%, closing at $6.24 [6][8].

Shares of cloud-based storage solutions provider Snowflake Inc. (NYSE: SNOW) lost 5.34% over the past month after gaining 11.97% the month prior. ...

Ford Motor Recalls Surge This week has been a rollercoaster ride for the auto industry. From tariff troubles to recall surges, rental program expansions, and breakthrough permits, the sector has seen it all. Here's a quick recap of the top stories that made headlines. Mazda Motor Faces Tariff Troubles President Donald Trump's tariffs continue to cast a shadow over Mazda Motor Corp. The Japanese auto giant, known for its passenger cars, trucks, and mini-vehicles, has reported billions in potential headwinds ...

Core Insights - Microsoft is experiencing challenges in selling its AI chatbot, Copilot, in the enterprise market, with some clients expressing reluctance to adopt it despite its capabilities [2][11][12] - The company has made significant investments in AI, particularly through its Azure cloud infrastructure, and reported a 40% revenue growth in Azure, surpassing competitors like Amazon Web Services and Google Cloud [3] - Microsoft is facing increased competition in the AI space from other vendors and startups, which is impacting its market position and sales strategies [8][17] Group 1: Product Adoption and Market Challenges - Over 150 million users are utilizing Microsoft's Copilot for various productivity tasks, but there are concerns about its value proposition, with some clients questioning the $30 per user monthly cost [1][12] - Microsoft has started offering a new tier for Copilot at $21 per user per month for organizations with up to 300 users, indicating a shift in pricing strategy to enhance adoption [12] - Conversations at the Ignite conference revealed that many IT buyers are hesitant to invest in Copilot licenses, with some clients stating they do not want the product at all [2][11] Group 2: Competitive Landscape - Microsoft is competing against other major players like Adobe, Google, and Salesforce in the AI market, which is becoming increasingly crowded [8] - OpenAI, a key partner, has also made significant commitments to AI development, further intensifying competition [3][10] - Companies are evaluating alternatives to Microsoft's AI products, indicating that Microsoft needs to adapt its sales approach to maintain its market share [17] Group 3: Client Engagement and Usage - More than 90% of Fortune 500 companies are using Microsoft 365 Copilot, with some organizations like Land O'Lakes and Pearson rolling it out to their entire workforce [13][15] - Daily active usage of Copilot among commercial sales, support, and partner services workers has increased from 20% to 70% over the past year, showing progress in user engagement [18] - Microsoft is integrating additional AI models from partners like Anthropic to enhance its offerings, which may improve its competitive edge [16]